Concepedia

Publication | Open Access

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

DOIFull Paper Access

65

Citations

30

References

2020

Year

Soo Chin Lee, Noriko Shimasaki, Joline S.J. Lim, Andrea Li‐Ann Wong, Kritika Yadav, Wei Peng Yong, Lip Kun Tan, Liang Piu Koh, Michelle Poon, Sing Huang Tan,
Clinical Cancer Research

Abstract

NK-cell therapy in combination with trastuzumab was well tolerated, with target engagement and preliminary antitumor activity, supporting continued assessment of this approach in phase II trials.

References

YearCitations

Page 1